These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 28302108)
1. Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015. Diawara S; Madamet M; Kounta MB; Lo G; Wade KA; Nakoulima A; Bercion R; Amalvict R; Gueye MW; Fall B; Diatta B; Pradines B Malar J; 2017 Mar; 16(1):118. PubMed ID: 28302108 [TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014. Fall B; Madamet M; Camara C; Amalvict R; Fall M; Nakoulima A; Diatta B; Diémé Y; Wade B; Pradines B Emerg Infect Dis; 2016 May; 22(5):841-5. PubMed ID: 27088703 [TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season. Fall B; Camara C; Fall M; Nakoulima A; Dionne P; Diatta B; Diemé Y; Wade B; Pradines B Malar J; 2015 Feb; 14():60. PubMed ID: 25849097 [TBL] [Abstract][Full Text] [Related]
4. Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study. Fall B; Pascual A; Sarr FD; Wurtz N; Richard V; Baret E; Diémé Y; Briolant S; Bercion R; Wade B; Tall A; Pradines B Malar J; 2013 Mar; 12():107. PubMed ID: 23510258 [TBL] [Abstract][Full Text] [Related]
5. Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs. Fall B; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Wade B; Bercion R; Pradines B Malar J; 2011 Oct; 10():310. PubMed ID: 22014157 [TBL] [Abstract][Full Text] [Related]
6. Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin. Wurtz N; Fall B; Pascual A; Fall M; Baret E; Camara C; Nakoulima A; Diatta B; Fall KB; Mbaye PS; Diémé Y; Bercion R; Wade B; Pradines B Antimicrob Agents Chemother; 2014 Dec; 58(12):7032-40. PubMed ID: 25199781 [TBL] [Abstract][Full Text] [Related]
7. Ex vivo susceptibility and genotyping of Plasmodium falciparum isolates from Pikine, Senegal. Mbaye A; Gaye A; Dieye B; Ndiaye YD; Bei AK; Affara M; Deme AB; Yade MS; Diongue K; Ndiaye IM; Ndiaye T; Sy M; Sy N; Koita O; Krogstad DJ; Volkman S; Nwakanma D; Ndiaye D Malar J; 2017 Jun; 16(1):250. PubMed ID: 28615016 [TBL] [Abstract][Full Text] [Related]
8. Low polymorphisms in pfact, pfugt and pfcarl genes in African Plasmodium falciparum isolates and absence of association with susceptibility to common anti-malarial drugs. Foguim FT; Robert MG; Gueye MW; Gendrot M; Diawara S; Mosnier J; Amalvict R; Benoit N; Bercion R; Fall B; Madamet M; Pradines B; Malar J; 2019 Aug; 18(1):293. PubMed ID: 31455301 [TBL] [Abstract][Full Text] [Related]
9. Association between Polymorphisms in the Pf Gendrot M; Diawara S; Madamet M; Kounta MB; Briolant S; Wade KA; Fall M; Benoit N; Nakoulima A; Amalvict R; Diémé Y; Fall B; Wade B; Diatta B; Pradines B Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052850 [TBL] [Abstract][Full Text] [Related]
10. Ex vivo activity of Proveblue, a methylene blue, against field isolates of Plasmodium falciparum in Dakar, Senegal from 2013-2015. Fall B; Madamet M; Diawara S; Briolant S; Wade KA; Lo G; Nakoulima A; Fall M; Bercion R; Kounta MB; Amalvict R; Benoit N; Gueye MW; Diatta B; Wade B; Pradines B Int J Antimicrob Agents; 2017 Aug; 50(2):155-158. PubMed ID: 28689867 [TBL] [Abstract][Full Text] [Related]
11. Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali. Traoré K; Diakité SAS; Bah S; Konaté DS; Dabitao D; Sanogo I; Sangaré M; Dama S; Keita B; Doumbouya M; Guindo MA; Doumbia S; Diakité M Drugs R D; 2020 Sep; 20(3):249-255. PubMed ID: 32557086 [TBL] [Abstract][Full Text] [Related]
12. In-vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area of high chloroquine resistance in Rwanda. Tinto H; Rwagacondo C; Karema C; Mupfasoni D; Vandoren W; Rusanganwa E; Erhart A; Van Overmeir C; Van Marck E; D'Alessandro U Trans R Soc Trop Med Hyg; 2006 Jun; 100(6):509-14. PubMed ID: 16337665 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014. Boussaroque A; Fall B; Madamet M; Wade KA; Fall M; Nakoulima A; Fall KB; Dionne P; Benoit N; Diatta B; Diemé Y; Wade B; Pradines B Malar J; 2016 Jul; 15(1):347. PubMed ID: 27387549 [TBL] [Abstract][Full Text] [Related]
14. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013. Torrentino-Madamet M; Fall B; Benoit N; Camara C; Amalvict R; Fall M; Dionne P; Ba Fall K; Nakoulima A; Diatta B; Diemé Y; Ménard D; Wade B; Pradines B Malar J; 2014 Dec; 13():472. PubMed ID: 25471113 [TBL] [Abstract][Full Text] [Related]
15. Absence of association between polymorphisms in the pfcoronin and pfk13 genes and the presence of Plasmodium falciparum parasites after treatment with artemisinin derivatives in Senegal. Delandre O; Daffe SM; Gendrot M; Diallo MN; Madamet M; Kounta MB; Diop MN; Bercion R; Sow A; Ngom PM; Lo G; Benoit N; Amalvict R; Fonta I; Mosnier J; Diawara S; Wade KA; Fall M; Fall KB; Fall B; Pradines B Int J Antimicrob Agents; 2020 Dec; 56(6):106190. PubMed ID: 33045351 [TBL] [Abstract][Full Text] [Related]
16. A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs. Quashie NB; Duah NO; Abuaku B; Quaye L; Ayanful-Torgby R; Akwoviah GA; Kweku M; Johnson JD; Lucchi NW; Udhayakumar V; Duplessis C; Kronmann KC; Koram KA Malar J; 2013 Dec; 12():450. PubMed ID: 24341604 [TBL] [Abstract][Full Text] [Related]
17. Plasmodium falciparum in vitro susceptibility to antimalarial drugs in Casamance (southwestern Senegal) during the first 5 years of routine use of artesunate-amodiaquine. Agnamey P; Brasseur P; de Pecoulas PE; Vaillant M; Olliaro P Antimicrob Agents Chemother; 2006 Apr; 50(4):1531-4. PubMed ID: 16569876 [TBL] [Abstract][Full Text] [Related]
18. Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso. Tahita MC; Tinto H; Yarga S; Kazienga A; Traore Coulibaly M; Valea I; Van Overmeir C; Rosanas-Urgell A; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Erhart A; D'Alessandro U Malar J; 2015 Jun; 14():251. PubMed ID: 26088768 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam. Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808 [TBL] [Abstract][Full Text] [Related]
20. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso. Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]